chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 4-5 days (around 02/17/2021)  after vaccine, my palm got very itchy and then it started to spread to various parts of my body. If I scratched it, it turned into a rash. When it first appeared it was like red streaky marks and if I could keep from scratching for 20 minutes it would subside, only to come back on a different body part at a different time. This is still happening. I contacted my Doctor and she said it sounded like my body was reacting to the proteins from vaccine and that it was causing my body to form antihistamines, so she recommended I started Zyrtec in morning and she suggested taking Benadryl before bed and they don't completely control it but it's better that I take antihistamine. Some days it's worse than others but it's still continuing. When I first contacted my Doctor I didn't see her in person but she consulted with dermatologist for me to use a steroid cream which didn't make a difference, so they tried a different steroid cream and that didn't work either. Lately I've been using Ceravae anti itch lotion and that seems to help. If I scratch it, my skin gets very red and sometimes I get hives from the scratching. The initial appearance is just a red streak on my skin that itches like crazy.
This spontaneous report as received from a nurse practitioner refers to a patient (reported as student) of unknown age. The patient's medical history was not reported. On an unknown date the patient was vaccinated with 1st dose of GARDASIL. Concomitant therapies included ATIVAN 1 milligram (mg) administered an hour before the GARDASIL. No adverse effects occurred after the first dose. On an unknown date the patient was vaccinated with 2nd dose of GARDASIL. ATIVAN 1 mg was administered an hour before the GARDASIL vaccination. On an unknown date (reported as within an unspecified period) after receiving GARDASIL the patient experienced lightheaded, dizzy, had a migraine, had insomnia, felt feverish, and had numbness on the right side of the face. The patient also had a neck pain. The patient experienced Bell's palsy within 24 hours of second dose as per diagnosis of another health care professional (HCP). Other symptoms included headaches, dizziness, insomnia and muscle pain. The outcome of lightheaded, dizzy, had a migraine, had insomnia, felt feverish, neck pain, numbness on the right side of the face and Bell's palsy was unknown. The relatedness of the events with the therapy was not reported. Additional information has been requested.
On January 20th I had a red itchy rash over many spots of my body. This progressed until January 23rd when the rash turned into hives. The joints in my hands, fingers, knees were swollen and in pain as well, when the hives progressed deeper into my skin. At this point I went to urgent care and was given a low dose of Methylprednisolone, which only helped with the swelling at the joints but did not help with the hives over the rest of my body. The hives progressed with no relief for about a week until I went to the ER and was given a larger one-time dose of a steroid and liquid Benadryl.  This gave me relief for about 24 hours. The rash/hives appeared anywhere on my body where there was pressure, and has since been identified as "Dermatographia - a condition in which lightly scratching your skin causes raised, red lines where you've scratched" by my allergist, Dr. The scratching and pressure not only caused red marks, but severe hives that are incredibly itchy and borderline painful. I have been taking a 24-hour regimen of various antihistamines since February 1st. I am currently taking a combination of one 24-hour dose of Allegra per day and 2 doses of Xyzar a day. I no longer get hives since starting this regimen, but I do still have the dermatographia which takes the form of red lines. It has now been almost 4 full months of this.
Throat tightening and feeling very sore when swallowing.  Wheezing and coughing up mucous, which seemed to be forming in my throat quickly.  Very red eyes, with mucous coming out of tear ducts.  Fever developed about an hour later, peaking at 102.5 (measured at ER) and disappearing within a couple of hours.  Vomiting about two hours into reaction.
Systemic: Allergic: Itch Generalized-Mild, Additional Details: Patient did not have any reaction immediately after receiving immunization.  However, several days later she called the pharmacy complaining about itching.
3-25-21 3:36PM PT 'FEELS SOB, ANXIOUS, CHEST TIGHT' . PT IS EXTREMELY ANXIOUS. STATES IT IS THE FIRST TIME SHE HAS BEEN OUT OF HER HOME IN OVER A YEAR. WATER, BATTERY OPERATED FAN AND COMFORT GIVEN. A/O, PINK, W/D. 3:48PM PT STATES 'FEELING A LITTLE BETTER'. 4:13PM TO EXIT WITH SON TO BE DRIVEN HOME. NO ACUTE DISTRESS. GAIT BRISK AND STEADY.
estimated to be due December 7, 2021. I didn't have any symptoms, I didn't feel like I lost the pregnancy, until we had ultrasound on May 14, 2021
Dx: atrial flutter I monitored pulse on iWatch during and after regular 3 mile hike. Pulse was higher than usual towards end of hike (up to 168 when usually not over 130). Hike ended at 10:40 AM and pulse stayed elevated in 130-140 range. I called advice nurse about 2 pm and went to urgent care where EKG was done and they sent me to Hospital ED where tests done and IV metoprolol administrated between 5:34 and 6 when oral tartrate version added. Pulse returned to normal range by 6:30 and I was discharged about 8:30. Referred  to cardiologist for followup.
Client seen by doctor in ER at approximately 8:00 PM on 8/13/04. Documentation states she had swelling and red area to left arm, and area hot to touch. Doctor diagnosed cellulitis and prescribed Keflex (250mg/5ml) 3ml 4 times per day for 7 days. When left arm checked on 8/16/04, red area and swelling were resolved.
Nurse administered vaccine to male patient using only the liquid adjuvant portion of the vaccin; Nurse administered vaccine to male patient using only the liquid adjuvant portion of the vaccin; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number 45L54, expiry date 18th May 2023) for prophylaxis.   On 28th March 2022, the patient received the 1st dose of Shingrix. On 28th March 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 28-Mar-2022 Reporter's Comment: The nurse administered Shingrix vaccine to patient using only the liquid adjuvant portion of the vaccine, it was not reconstituted with the lyophilized powder portion and adjuvant was administered, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. At the time of reporting, the dose had not been repeated. The reporter consented to follow up.
On 11 days after getting vaccine got hives on the arm it was given on 3/22/2021
SUSPECTED CLINICAL VACCINATION FAILURE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via a company representative concerned a 32 year old male. The patient's weight was 180 pounds, and height was 74 inches. The patient's pre-existing medical conditions included: Patient had no known drug allergies. The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported and batch number:1802070 expiry: 23-AUG-2021) dose was not reported, 1 total administered at right arm on 05-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 09-SEP-2021, the patient experienced suspected clinical vaccination failure and suspected Covid-19 infection. Laboratory data included: COVID-19 virus test positive (NR: not provided) positive. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the suspected Covid-19 infection and suspected clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210920642-COVID-19 VACCINE AD26.COV2.S - Suspected clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 12Sep2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 37 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "not recovered" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient had received the treatment of COVID-19 as Paxlovid on 10Sep2023 to 14Sep2023.  The information on the batch/lot number for [BNT162B2, BNT162B2 OMI BA.4-5] has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300307909 same patient, different drug/event;
This case was reported by a consumer via call center representative and described the occurrence of headache in a elderly female patient who received SINGRIX for prophylaxis. Previously administered products included SHINGRIX (1st dose). On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced headache, chills, injection site swelling and general body pain. On an unknown date, the outcome of the headache, chills, injection site swelling and general body pain were recovered/resolved. It was unknown if the reporter considered the headache, chills, injection site swelling and general body pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter was the brother in law of the patient. The reporter did not have details of when events started or how long they lasted. This case has been linked with US2018115927, reported by the same reporter.
temperature excursion; This spontaneous report was received from a medical student, referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concurrent condition, drug reactions/allergies and concomitant medication was not provided.  On 16-NOV-2021, the patient was vaccinated with improper stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot# T034880, but upon internal validation established as non-valid, dose, route and strength were not provided) for prophylaxis. The vaccine administered experienced temperature excursions of 50.29 Degree Fahrenheit for 2 hours (product storage error). There was no previous temperature excursion.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. In approximately September 2014 (reported as "about week ago") the patient was vaccinated with ZOSTAVAX, 0.65 ml, subcutaneously. In approximately September 2014 (also reported as "now") the patient experienced redness at the injection site. It was also reported that injection site was red and swelling "with the head". Reporter stated that there were no rash or lesions. No treatment was given for adverse events. No lab diagnostic studies were performed. The outcome of events was reported as not recovered/not resolved. Relatedness between events and vaccination was not reported. Additional information has been requested.
R sided paresthesias started at 8pm on 4/24/21 and worsened to entire R side of body on 4/25/21 am. He was evaluated and admitted to the hospital 4/25/21 and found to have left thalamic stroke. No weakness in arm noted but some R hand dysmetria along with decreased sensation.
Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 29-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 29-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not reported. It was reported that the vaccine was stored in the freezer and they would take out one to two vials and keep in the fridge as needed each day. It was reported that no treatment was provided to the patients.
I am an RN. Got my first Covid vaccine on Jan 9th 2021. A week later my eyes burned and itched horribly. Also my scalp itched terribly. Never had this in my life. I used some eye drops and in a few days it went away. 28 days later, got my 2nd Covid vaccine. Again about 5 days later my eyes are burning and itching as well. I have never had allergies to anything. I am again putting eye drops in. Systane and Visine. I also have gotten a very tiny blister below my right eye. Very tiny..smaller than a pea. I don't see this side effect anywhere written. I am not allergic to dust or animal dander. I am 63 years old. Just wanted you to be aware, I believe this is caused by the vaccine.
fever 102-103; edema & redness of rt arm down to wrist; 7JAN93 tc to mom pt better cont w/low fever & rt arm @ site of inject red;
After 2nd dose, malaise day after shot. No fever. No troubel breathing. No loss of vision. Did have 2nd cataract surgery between 1st and 2nd dose. Developed numbness on left side toward eye on or about 2 week prior to 2nd dose (on 2/29/21). Additional numbing sensation started across the face (around the mouth and across the eye area) the night after the 2nd dose. Still there.  Doesn't seem to have worsed or improved at the time of this report.  Had eye Dr. appointment today (3/3/21) and he stated he didn't have any answers as to why this was occurring. Patient didn't report until today thinking it was related to eye surgeries. 1st dose 1/25/2021  2nd dose 2/22/21
Information has been received on 02/24/2002 from a consumer concerning her daughter who "several years ago" was vaccinated with one dose of varicella virus vaccine live. Subsequently the pt experienced "a possible side effect to it." Additional info has been requested.
1) Irritability and temp 99-100F began 24 hrs after receiving shots.  Continues at day 7. 2) New onset stuttering began 5 days after shots and continues.
Sciatica (went to urgent care 2x for meds due to flare-up), high blood pressure (was under control with meds before the vaccine, then went up to 144/95, had to add another med to get it back under control), headache or migraine everyday since the vaccine.
COULD NOT STAND; VERTIGO; no balance; ADVERSE REACTION; EXTREMLY DIZZY; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (ADVERSE REACTION), DIZZINESS (EXTREMLY DIZZY), DIZZINESS POSTURAL (COULD NOT STAND), VERTIGO (VERTIGO) and BALANCE DISORDER (no balance) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ADVERSE REACTION (ADVERSE REACTION) and DIZZINESS (EXTREMLY DIZZY). On 03-Mar-2021, the patient experienced DIZZINESS POSTURAL (COULD NOT STAND), VERTIGO (VERTIGO) and BALANCE DISORDER (no balance). At the time of the report, ADVERSE REACTION (ADVERSE REACTION), DIZZINESS (EXTREMLY DIZZY), DIZZINESS POSTURAL (COULD NOT STAND), VERTIGO (VERTIGO) and BALANCE DISORDER (no balance) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not reported.   Treatment information was not provided.
Breakthrough case admission after two doses Moderna 4/24/21 Lot# 016C21A Moderna 5/22/21 Lot# 033C21A
This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received SHINGRIX for prophylaxis. In June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient reported that she might have had a shingles episode after receiving SHINGRIX. The reporter ended call before more information could be obtained.
A report was received from a health care professional in the USA on 7/5/04 concerning a 1 year old female vaccinee who inadvertently received Fluvirin on 10/29/03. This report was received as follow up and involves a group of 10 children under the age of 4 years who inadvertently received Fluvirin instead of the product approved for pediatric use in the USA. None of the vaccinees experienced any adverse effects. No further information is expected.
1hr p/vax 30OCT98  arm red & swollen @ site;DPH given;seen @ ER arm swollen, painful;DPH given seen by MD 2NOV98;cont DPH, elevated arm stay out of work for 2 days;arm red, warm, swollen down to fingers;
Right shoulder, large hard lump; Shoulder is now very painful, aching; Shoulder is now popping; Very hard to move shoulder; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 29Mar2021 at 08:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included arthritis, depression, anxiety and panic disorder. The patient was not aware of any known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 20Apr2021, the patients' right shoulder had large hard lump that was still there (at the time of reporting). Her shoulder was very painful, aching, popping and very hard to move shoulder. The events did not result in doctor or other health care professional office or clinic visit, emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events large hard lump on right shoulder, shoulder was very painful, aching, popping and very hard to move shoulder was not resolved at the time of this report.
Benign paroxysmal positional vertigo (BPPV), epley maneuver, mild improvement
Spoke with mom states that pt was seen Monday and given immunizations, that night pt was jittery and vomited x2 in evening, since then has had what looks like petechiae on face and face has appeared a little swollen. Also complained of severe HA where he was screaming in pain. Dad stated that he has never done this in his life. Petechaie noted under eyes and started resolving within 4 days. No other symptoms after that initial episode.
First there was a mild headache now she is throwing up can't even keep water down for 24 hours now.
Possible TIA. I had speech problems first (stuttering, slurring ) followed by numbness in arm and leg on left side. Twitching in left eye and left side of mouth  Symptoms resolved aprox 3-4 hrs after onset
Itching spread to right arm.; went to the dermatologist on 3/24 and was diagnosed with nummular eczema; After two weeks, spots began on the right leg. They were distinctive round shape about the size of a quarter or less. They were scaly; itchy bumps near elbow of left arm; extremely nauseous for 48 hours immediately following the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 at 10:00(at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included seasonal allergy. Concomitant medications included cetirizine hydrochloride (ZYRTEC, 10mg) taken within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On 25Feb2021 the patient experienced extremely nauseous for 48 hours immediately following the vaccine. On 26Feb2021, at 14:00 after 28 hours following the vaccination, the patient experienced itchy bumps near elbow of left arm. After a few days, itching spread to right arm.  On an unknown date in Mar2021, after two weeks the patient experienced spots on the right leg. They were distinctive round shape about the size of a quarter or less. They were scaly. They got worse when the patient was hot or wearing stiff pants like jeans. The patient did not get the 2nd dose as scheduled.  On 24Mar2021 the patient was diagnosed with nummular eczema. Therapeutic measures included treatment with Steroid cream.  The event resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event nausea immediately following the vaccine was recovered in 48 hours on 27Feb2021. The clinical outcome of the events itchy rash, itching, eczema nummular, scaly rash were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information was received from a pharmacist concerning a 40 year old patient. The patient's medical history included a brain tumor. On an unknown date the patient was vaccinated with ZOSTAVAX 0.65 ml. Subcutaneous. No adverse effect has been reported. No additional information reported. Additional information has been requested.
bacterial pneumonia -- treated with course of antibiotics. Neither I nor more doctor feels that this is related to the vaccine but I received a message from you requesting more information
Shortness of breath on day 3 after dose 1 and chest pain/dizziness on day 5 after receiving dose 1  Had to go to a cardiologist for EKG, and further testing